These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2475079)

  • 21. Inhibitors of the fibrinolytic enzyme system.
    Aoki N; Harpel PC
    Semin Thromb Hemost; 1984 Jan; 10(1):24-41. PubMed ID: 6199845
    [No Abstract]   [Full Text] [Related]  

  • 22. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
    Koyama T; Aoki N
    Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysis.
    Speiser W; Pabinger-Fasching I; Kyrle PA; Kapiotis S; Kottas-Heldenberg A; Bettelheim P; Lechner K
    Blut; 1990 Nov; 61(5):298-302. PubMed ID: 2271776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel SERPINF2 variant causing severe alpha-2-antiplasmin deficiency.
    Egan G; Pluthero FG; Bouskill V; Hilliard P; Drury LJ; Carcao MD; Kahr WHA
    Br J Haematol; 2019 Sep; 186(6):e198-e201. PubMed ID: 31282989
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency.
    Kordich L; Feldman L; Porterie P; Lago O
    Thromb Res; 1985 Dec; 40(5):645-51. PubMed ID: 4089832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of alpha 2-antiplasmin in the defibrination syndrome.
    Wolf PL
    Arch Intern Med; 1989 Aug; 149(8):1724-5. PubMed ID: 2475077
    [No Abstract]   [Full Text] [Related]  

  • 29. Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy.
    Takahashi R; Ono K; Ikeda T; Akagi A; Noto D; Nozaki I; Sakai K; Asakura H; Iwasa K; Yamada M
    Amyloid; 2012 Sep; 19(3):129-32. PubMed ID: 22624582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
    Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
    Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic fibrinolysis as a cause of clinical bleeding.
    Stump DC; Taylor FB; Nesheim ME; Giles AR; Dzik WH; Bovill EG
    Semin Thromb Hemost; 1990 Jul; 16(3):260-73. PubMed ID: 2237447
    [No Abstract]   [Full Text] [Related]  

  • 35. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of fibrinolysis.
    Juhan-Vague I; Alessi MC; Declerck PJ
    Baillieres Clin Haematol; 1995 Jun; 8(2):329-43. PubMed ID: 7549066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis.
    Marongiu F; Mamusa AM; Mameli G; Mulas G; Solinas A; Demelia L; Contu L
    Thromb Res; 1985 Jan; 37(2):287-94. PubMed ID: 3975873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.